Breast cancer
Results
Phase 3
This trial compared external radiotherapy with radiotherapy given during surgery (intra operative radiotherapy) for breast cancer.
When this trial was done, the standard radiotherapy treatment for breast cancer was external radiotherapy. Having radiotherapy reduces the chance of breast cancer coming back after surgery.
With external radiotherapy, you go to the radiotherapy department for daily treatment once you have recovered from surgery. This is a little like having an X-ray and takes a few minutes each time. The usual treatment is radiotherapy 5 days a week, for up to 6 weeks. This is called a course of radiotherapy.
In this trial, some people had a single dose of radiotherapy during surgery instead of a course of radiotherapy afterwards. This is called intra operative radiotherapy, or IORT. The surgeon puts an applicator into the breast during surgery. The applicator delivers radiotherapy directly to the breast tissue.
The main aim of this trial was to see if intra operative radiotherapy is as good as external radiotherapy at stopping breast cancer coming back after surgery.
Recruitment start: 24 March 2000
Recruitment end: 25 June 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor J S Vaidya
Professor J S Tobias
Professor Michael Baum
NIHR Health Technology Assessment (HTA) programme
NIHR Clinical Research Network: Cancer
NIHR University College London Hospitals Biomedical Research Centre
UCLH Charities
Ninewells Cancer Campaign
National Health and Medical Research Council, Australia
German Federal Ministry of Education and Research
Carl Zeiss
There is more information available on the Targit website.
Last reviewed: 21 May 2015
CRUK internal database number: 500